Raiza B. Peres
Rio De Janeiro, RJ 10360040, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds.
Journal: Acta tropica
Published: February 23, 2023
In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on Trypanosoma cruzi.
Journal: Molecules (Basel, Switzerland)
Published: June 24, 2021
Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi.
Journal: Frontiers in cellular and infection microbiology
Published: October 15, 2020
Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi Y strain (DTU TcII): in vitro and in vivo studies.
Journal: Parasitology
Published: June 13, 2020
Tetrahydrophthalazinone Inhibitor of Phosphodiesterase with In Vitro Activity against Intracellular Trypanosomatids.
Journal: Antimicrobial agents and chemotherapy
Published: May 11, 2020
Evaluation of phthalazinone phosphodiesterase inhibitors with improved activity and selectivity against Trypanosoma cruzi.
Journal: The Journal of antimicrobial chemotherapy
Published: July 19, 2019
Repurposing Strategy of Atorvastatin against Trypanosoma cruzi: In Vitro Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal Activity.
Journal: Antimicrobial agents and chemotherapy
Published: May 14, 2018
Identification and preliminary structure-activity relationship studies of novel pyridyl sulfonamides as potential Chagas disease therapeutic agents.
Journal: Bioorganic & medicinal chemistry letters
Published: March 15, 2018
New 1,2,3-triazole-based analogues of benznidazole for use against Trypanosoma cruzi infection: In vitro and in vivo evaluations.
Journal: Chemical biology & drug design
Published: February 20, 2018
Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
Journal: European journal of medicinal chemistry
Published: December 19, 2017
Last Updated: 09/26/2026